X4 Pharmaceuticals's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; X4 Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is €-0.14. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 49.00K	$ 49.00K	$ 48.00K	$ 49.00K	$ 98.00K
Gross Profit	$ 49.00K	$ 49.00K	$ 48.00K	$ 49.00K	$ 98.00K
EBIT	$ -17.21M	$ -645.00K	$ -54.55M	$ -29.18M	$ -28.14M
EBITDA	$ -17.15M	-	-	$ 0.00	$ -28.02M
Net Income Common Stockholders	$ -19.13M	$ -2.31M	$ -55.71M	$ -24.02M	$ -29.10M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 114.22M	$ 141.68M	$ 141.31M	$ 93.41M	$ 121.72M
Total Assets	$ 147.26M	$ 173.29M	$ 173.40M	$ 123.42M	$ 154.48M
Total Debt	$ 3.71M	$ 3.96M	$ 5.04M	$ 5.11M	$ 6.12M
Net Debt	$ -110.50M	$ -137.72M	$ -136.27M	$ -88.30M	$ -115.60M
Total Liabilities	$ 96.16M	$ 105.70M	$ 105.86M	$ 72.73M	$ 155.59M
Stockholders Equity	$ 51.10M	$ 67.59M	$ 67.50M	$ 51.63M	$ 74.05M
Cash Flow	-
Free Cash Flow	$ -27.77M	-	-	-	$ -19.13M
Operating Cash Flow	$ -27.73M	$ -20.83M	-	-	$ -19.09M
Investing Cash Flow	$ -4.83M	$ -5.16M	-	-	$ -34.00K
Financing Cash Flow	$ 97.00K	$ 21.20M	-	-	$ 60.64M

Currency in USD

X4 Pharmaceuticals Earnings and Revenue History

Income Statement >

X4 Pharmaceuticals Debt to Assets

Balance Sheet >

X4 Pharmaceuticals Cash Flow

Cash Flow >

X4 Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing